Industry-Backed Drug Tracking System Gone From FDA Bill

Law360, New York (June 18, 2012, 8:37 PM EDT) -- The failure to get nationwide drug tracking standards into the U.S. Food and Drug Administration user fee bill, confirmed Monday by several sources, was a blow to a broad swath of the pharmaceutical industry that hoped national standards would preempt more stringent state laws.

The track-and-trace proposal was written by a coalition of major industry groups representing drug companies, distributors, pharmacies and UPS Inc., which said it would prevent counterfeit or adulterated drugs from entering the supply chain. Negotiations to make the language acceptable to all...
To view the full article, register now.